Ritodrine is a beta agonist used to treat preterm labor. It works by relaxing the smooth muscles of the uterus, which can help to delay or stop preterm labor. Ritodrine is usually given as a continuous intravenous (IV) infusion over several hours. It is typically used when other treatments, such as rest and hydration, have not been successful in preventing preterm labor. Ritodrine is not recommended for use during the last 3 weeks of pregnancy.
Ritodrine is a medication that was previously used to stop premature labor. It is a tocolytic drug, which means it works by relaxing the muscles in the uterus to prevent contractions. Ritodrine was available in oral tablets or as an injection, but it has been withdrawn from the market in many countries, including the United States, due to safety concerns.
Here's a breakdown of how Ritodrine worked:
- Type of drug: Beta-2 adrenergic agonist
- Mechanism of action: Ritodrine relaxes the uterus by stimulating beta-2 receptors on the surface of uterine muscle cells. This stimulation increases the production of a molecule called cyclic adenosine monophosphate (cAMP), which in turn decreases the concentration of calcium inside the muscle cells. Calcium is necessary for muscle contraction, so a decrease in calcium levels leads to relaxation of the uterine muscles and reduces contractions.
Ritodrine is no longer a preferred medication for treating preterm labor because other medications, such as terbutaline, are considered to be safer and more effective.